Keywords
HematologyInternal medicineMedicine
Affiliated Institutions
Related Publications
Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management
Disease overview : Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1–2 cases per 100,000 adults, and accounts for ∼15% of newly diagnosed ca...
Chronic Myelogenous Leukemia, Version 1.2015
Chronic myelogenous leukemia (CML) is usually diagnosed in the chronic phase. Untreated chronic phase CML will eventually progress to advanced phase (accelerated or blast phase)...
Diagnosing and Managing Advanced Chronic Myeloid Leukemia
Clinical staging of chronic myeloid leukemia (CML) distinguishes between chronic phase (CP-CML), accelerated phase (AP-CML), and blastic phase (BP-CML), reflecting its natural h...
Oncogenic<i>CSF3R</i>Mutations in Chronic Neutrophilic Leukemia and Atypical CML
Mutations in CSF3R are common in patients with CNL or atypical CML and represent a potentially useful criterion for diagnosing these neoplasms. (Funded by the Leukemia and Lymph...
Human tumors studied with genetic markers.
Genetic marker systems have been employed to investigate the origin and development of many human tumors. The type of information already gained with such systems includes the p...
Publication Info
- Year
- 2015
- Type
- editorial
- Volume
- 94
- Issue
- S2
- Pages
- 103-105
- Citations
- 26
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
26
OpenAlex
Cite This
Rüdiger Hehlmann
(2015).
CML—where do we stand in 2015?.
Annals of Hematology
, 94
(S2)
, 103-105.
https://doi.org/10.1007/s00277-015-2331-1
Identifiers
- DOI
- 10.1007/s00277-015-2331-1